Delivery Order SPE2DB20D1047-SPE2DB24FF44D

Award Date 2/6/24
Potential Completion Date 2/7/24
Potential Value $21K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract with a potential value of $1,741.62 by the Defense Logistics Agency (DLA) to provide OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31,...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order worth $1,741.62 by the Defense Logistics Agency (DLA) to provide OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product, with a completion date of February 16, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen Drug Corp and DLA, which serves as the primary contract vehicle for...
Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML pharmaceutical products. The contract has a potential value of $62,158.46 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is not designated as a set-aside. This award is associated with a larger indefinite delivery...
The U.S. Defense Logistics Agency (DLA) awarded a $1,741.62 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4564605282 OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML pharmaceutical product to the government. This delivery order contract is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical for the provision of $3,483.24 worth of OZEMPIC 0.25-0.5MG 1S pharmaceutical products. The order has a completion date of February 26, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $3,900.16 firm fixed price delivery order from the Defense Logistics Agency (DLA) to provide OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $1,741.62 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide the pharmaceutical product OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA, which serves as the primary contract vehicle for the company to...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a Firm Fixed Price Delivery Order by the Defense Logistics Agency (DLA) to provide the pharmaceutical product OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML. The award has a potential value of $1,161.08 and a performance period through February 21, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through...
This federal contract award is a $2,758.44 firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, with a completion date of February 22, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will deliver this product to support military treatment programs and facilities. Amerisourcebergen...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is valued at $11,533.00 and has an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp will provide the DLA with the pharmaceutical product OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML. This delivery order is part of a larger indefinite delivery contract...
  • SPE2DB20D1047
    Indefinite Delivery Contract
  • SPE2DB20D1047-SPE2DB24FF44D
    Delivery Order

Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order worth $21,480.91 by the Defense Logistics Agency (DLA) for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML pharmaceutical products. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This contract award does not have a set-aside designation.

Generated 5/7/24, 11:20 AM